UBS Group’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16
| Closed | -$16 | – | 9016 |
|
|
2025
Q1 | $16 | Hold |
16
| – | – | ﹤0.01% | 8784 |
|
|
2024
Q4 | $19 | Sell |
16
-3,201
| -100% | -$3.8K | ﹤0.01% | 8530 |
|
|
2024
Q3 | $5.41K | Buy |
3,217
+3,201
| +20,006% | +$5.38K | ﹤0.01% | 6848 |
|
|
2024
Q2 | $23 | Sell |
16
-3,053
| -99% | -$4.39K | ﹤0.01% | 8135 |
|
|
2024
Q1 | $11.6K | Sell |
3,069
-594
| -16% | -$2.25K | ﹤0.01% | 5999 |
|
|
2023
Q4 | $9.89K | Buy |
3,663
+2,973
| +431% | +$8.03K | ﹤0.01% | 6258 |
|
|
2023
Q3 | $1.09K | Sell |
690
-17,120
| -96% | -$27K | ﹤0.01% | 6964 |
|
|
2023
Q2 | $46.8K | Sell |
17,810
-13,643
| -43% | -$35.8K | ﹤0.01% | 5452 |
|
|
2023
Q1 | $114K | Sell |
31,453
-1,992
| -6% | -$7.25K | ﹤0.01% | 4748 |
|
|
2022
Q4 | $132K | Buy |
33,445
+1,574
| +5% | +$6.2K | ﹤0.01% | 4727 |
|
|
2022
Q3 | $136K | Buy |
31,871
+13,490
| +73% | +$57.6K | ﹤0.01% | 4397 |
|
|
2022
Q2 | $83K | Buy |
18,381
+698
| +4% | +$3.15K | ﹤0.01% | 4560 |
|
|
2022
Q1 | $99K | Sell |
17,683
-3,963
| -18% | -$22.2K | ﹤0.01% | 4919 |
|
|
2021
Q4 | $135K | Buy |
21,646
+6,192
| +40% | +$38.6K | ﹤0.01% | 4962 |
|
|
2021
Q3 | $152K | Buy |
15,454
+2,034
| +15% | +$20K | ﹤0.01% | 4474 |
|
|
2021
Q2 | $120K | Buy |
13,420
+2,548
| +23% | +$22.8K | ﹤0.01% | 4710 |
|
|
2021
Q1 | $120K | Sell |
10,872
-11,527
| -51% | -$127K | ﹤0.01% | 4842 |
|
|
2020
Q4 | $189K | Buy |
22,399
+12,169
| +119% | +$103K | ﹤0.01% | 4304 |
|
|
2020
Q3 | $61K | Buy |
10,230
+9,886
| +2,874% | +$58.9K | ﹤0.01% | 4655 |
|
|
2020
Q2 | $2K | Buy |
+344
| New | +$2K | ﹤0.01% | 6762 |
|
|
2020
Q1 | – | Sell |
-2,873
| Closed | -$24K | – | 7047 |
|
|
2019
Q4 | $24K | Sell |
2,873
-308
| -10% | -$2.57K | ﹤0.01% | 5706 |
|
|
2019
Q3 | $85K | Buy |
3,181
+1,641
| +107% | +$43.8K | ﹤0.01% | 4932 |
|
|
2019
Q2 | $33K | Buy |
+1,540
| New | +$33K | ﹤0.01% | 5384 |
|
|
2019
Q1 | – | Sell |
-615
| Closed | -$4K | – | 6909 |
|
|
2018
Q4 | $4K | Buy |
+615
| New | +$4K | ﹤0.01% | 6691 |
|
|
2018
Q3 | – | Sell |
-278
| Closed | -$4K | – | 7057 |
|
|
2018
Q2 | $4K | Sell |
278
-12
| -4% | -$173 | ﹤0.01% | 6611 |
|
|
2018
Q1 | $5K | Buy |
290
+5
| +2% | +$86 | ﹤0.01% | 6331 |
|
|
2017
Q4 | $5K | Buy |
+285
| New | +$5K | ﹤0.01% | 6390 |
|
|
2017
Q3 | – | Sell |
-155
| Closed | -$4K | – | 6798 |
|
|
2017
Q2 | $4K | Sell |
155
-75
| -33% | -$1.94K | ﹤0.01% | 6250 |
|
|
2017
Q1 | $7K | Buy |
230
+128
| +125% | +$3.9K | ﹤0.01% | 5882 |
|
|
2016
Q4 | $4K | Sell |
102
-36
| -26% | -$1.41K | ﹤0.01% | 6336 |
|
|
2016
Q3 | $10K | Buy |
+138
| New | +$10K | ﹤0.01% | 5860 |
|
|
2016
Q2 | – | Sell |
-42
| Closed | -$4K | – | 6813 |
|
|
2016
Q1 | $4K | Sell |
42
-131
| -76% | -$12.5K | ﹤0.01% | 6215 |
|
|
2015
Q4 | $27K | Buy |
+173
| New | +$27K | ﹤0.01% | 5286 |
|
|
2015
Q3 | – | Sell |
-87
| Closed | -$24K | – | 6866 |
|
|
2015
Q2 | $24K | Buy |
+87
| New | +$24K | ﹤0.01% | 5353 |
|